These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 8035024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
    Kamai Y, Kakuta M, Shibayama T, Fukuoka T, Kuwahara S.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):52-6. PubMed ID: 15616275
    [Abstract] [Full Text] [Related]

  • 7. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E, Bilgen H, Cerikçioğlu N, Ilki A, Ulger N, Bakır M, Akman I, Ozek E.
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [Abstract] [Full Text] [Related]

  • 8. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP.
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [Abstract] [Full Text] [Related]

  • 9. [Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Czaika V, Tietz HJ, Schmalreck A, Sterry W, Schultze W.
    Mycoses; 2000 Sep; 43 Suppl 2():45-50. PubMed ID: 11291577
    [Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Nolte FS, Parkinson T, Falconer DJ, Dix S, Williams J, Gilmore C, Geller R, Wingard JR.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
    [Abstract] [Full Text] [Related]

  • 11. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M, Pastor FJ, Capilla J, Sutton DA, Fothergill AW, Guarro J.
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis.
    Longman LP, Hibbert SA, Martin MV.
    Rev Infect Dis; 1990 Feb; 12 Suppl 3():S294-8. PubMed ID: 2184507
    [Abstract] [Full Text] [Related]

  • 13. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA, Okogbule-Wonodi I, Bhat N, Sanati H.
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [Abstract] [Full Text] [Related]

  • 14. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT, Findik D, Senkeles C, Arslan U.
    Ann Clin Microbiol Antimicrob; 2016 May 31; 15(1):36. PubMed ID: 27245756
    [Abstract] [Full Text] [Related]

  • 15. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A, Yacouba A, Bamba S, Sangare I, Sawadogo M, Guiguemde T, Kone S, Traore LK, Ouedraogo-Traore R, Guiguemde RT.
    J Mycol Med; 2017 Dec 31; 27(4):469-475. PubMed ID: 28754462
    [Abstract] [Full Text] [Related]

  • 16. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K, Pastor FJ, Capilla J, Sutton DA, Mayayo E, Fothergill AW, Guarro J.
    Rev Iberoam Micol; 2015 Dec 31; 32(1):34-9. PubMed ID: 24594291
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
    Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ, Jones RN.
    Diagn Microbiol Infect Dis; 2004 Feb 31; 48(2):101-5. PubMed ID: 14972378
    [Abstract] [Full Text] [Related]

  • 18. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
    Najvar LK, Correa A, James P, Luther MF, Graybill JR.
    J Antimicrob Chemother; 1996 Oct 31; 38(4):671-7. PubMed ID: 8937961
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
    Ding CH, Wahab AA, Muttaqillah NA, Tzar MN.
    J Pak Med Assoc; 2014 Dec 31; 64(12):1375-9. PubMed ID: 25842581
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
    Willinger B, Apfalter P, Hirschl AM, Makristathis A, Rotter M, Seibold M.
    Diagn Microbiol Infect Dis; 2000 Sep 31; 38(1):11-5. PubMed ID: 11025178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.